Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?

Santos-Moreno, Pedro; Buitrago-Garcia, Diana; Villarreal, Laura; Aza, Anggie; Cabrera, Michael; Rivero, Wilberto; Rojas-Villarraga, Adriana

Santos-Moreno, Pedro; Buitrago-Garcia, Diana; Villarreal, Laura; Aza, Anggie; Cabrera, Michael; Rivero, Wilberto; Rojas-Villarraga, Adriana.

Santos-Moreno P; Rheumatology, Biomab IPS, Bogotá, Colombia pedrosantosmoreno@hotmail.com.
Buitrago-Garcia D; Epidemiology, Biomab IPS, Bogotá, Colombia.
Villarreal L; Rheumatology, Biomab IPS, Bogotá, Colombia.
Aza A; Rheumatology, Biomab IPS, Bogotá, Colombia.
Cabrera M; Statistics and Clinical Reports, Biomab IPS, Bogotá, Colombia.
Rivero W; Pharmacy and Pharmacovigilance, Biomab IPS, Bogotá, Colombia.
Rojas-Villarraga A; Research Department, Fundación Universitaria de Ciencias de la Salud-FUCS, Bogotá, Colombia.

Ann Rheum Dis ; 81(8): e154, 2022 08.

Article in English | MEDLINE | ID: covidwho-651972

Subject(s)

Antimalarials; COVID-19; Antimalarials/adverse effects; Chloroquine; Fear; Humans; Hydroxychloroquine/adverse effects

Keywords

arthritis, rheumatoid; cardiovascular diseases; hydroxychloroquine; outcome assessment, health care

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Antimalarials Limits: Humans Language: English Journal: Ann Rheum Dis Year: 2022 Document Type: Article Affiliation country: Annrheumdis-2020-218259

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google